1-9 of 9
Paolo Fiumara
Close
Sort by
Journal Articles

Absolute Count of Myeloid Derived Suppressor Cells (MDSC) Is Able to Predict the Response to Early-PET In Hodgkin Lymphoma

Alessandra Romano, MD, Nunziatina Parrinello, Calogero Vetro, MD, Piera La Cava, PhD, Daniela Donnarumma, MD, Concetta Conticello, MD, Ugo Consoli, MD, Paolo Fiumara, MD, Annalisa Chiarenza, MD, Giuseppe A Palumbo, MD, Massimo Ippolito, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2010) 116 (21): 3882.
https://doi.org/10.1182/blood.V116.21.3882.3882
Published: 2010
Journal Articles

Myeloid-Derived Suppressor Cells in Patients with Hodgkin Lymphoma.

Nunziatina Parrinello, Piera La Cava, Daniele Tibullo, Cesarina Giallongo, Orazio Di Bartolo, Paolo Spina, Paolo Fiumara, Luciana Schinocca, Concetta Conticello, Annalisa Chiarenza, Giuseppe A Palumbo, Francesco Di Raimondo
Journal: Blood
Blood (2009) 114 (22): 3662.
https://doi.org/10.1182/blood.V114.22.3662.3662
Published: 2009
Journal Articles

Lenalidomide IS Able to Restore Immune SYSTEM IN MULTIPLE MYELOMA PATIENTS.

Annalisa Chiarenza, Nunziatina Parrinello, Piera La Cava, Eleonora Spina, Daniele Tibullo, Cesarina Giallongo, Maide Cavalli, Alessandra Romano, Paolo Fiumara, Giuseppe A Palumbo, Francesco Di Raimondo
Journal: Blood
Blood (2009) 114 (22): 4909.
https://doi.org/10.1182/blood.V114.22.4909.4909
Published: 2009
Journal Articles

Salvage Therapy with Intravenous Liposomal Adryamicin (A), Bortezomib (B), Cyclophosphamide (C), and Dexamethasone (D) (ABCD) in Previously Treated Myeloma Patients

Francesco Di Raimondo, Alessandra Romano, Ausilia Gorgone, Annalisa Chiarenza, Maide Cavalli, Salvatore Berretta, Paolo Fiumara, Giovanna Motta, Giuseppe A. Palumbo
Journal: Blood
Blood (2008) 112 (11): 2779.
https://doi.org/10.1182/blood.V112.11.2779.2779
Published: 2008
Journal Articles

Salvage Therapy with Intravenous Bortezomib, Melphalan and Dexamathasone in Previously Treated Myeloma Patients.

Francesco Di Raimondo, MD, Annalisa Chiarenza, MD, Alessandra Romano, MD, Vittorio Del Fabro, MD, Luciana Schinocca, MD, Paolo Fiumara, MD, Concetta Conticello, MD, Gabriella Amato, MD, Giuseppe A. Palumbo, MD, Rosario Giustolisi, MD
Journal: Blood
Blood (2007) 110 (11): 2728.
https://doi.org/10.1182/blood.V110.11.2728.2728
Published: 2007
Journal Articles

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

Bei Zheng, Paolo Fiumara, Yang V. Li, Georgios Georgakis, Virginia Snell, Mamoun Younes, Jean Nicolas Vauthey, Antonino Carbone, Anas Younes
Journal: Blood
Blood (2003) 102 (3): 1019–1027.
https://doi.org/10.1182/blood-2002-11-3507
Published: 2003
Journal Articles

Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers

Paolo Fiumara, Fernando Cabanillas, Anas Younes
Journal: Blood
Blood (2001) 98 (9): 2877–2878.
https://doi.org/10.1182/blood.V98.9.2877
Published: 2001
Journal Articles

Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines

Paolo Fiumara, Virginia Snell, Yang Li, Asok Mukhopadhyay, Mamoun Younes, Ann Marie Gillenwater, Fernando Cabanillas, Bharat B. Aggarwal, Anas Younes
Journal: Blood
Blood (2001) 98 (9): 2784–2790.
https://doi.org/10.1182/blood.V98.9.2784
Published: 2001
Journal Articles

Successful Healing of Hydroxyurea-Related Leg Ulcers With Topical Granulocyte-Macrophage Colony-Stimulating Factor

Fabio Stagno, Patrizia Guglielmo, Ugo Consoli, Paolo Fiumara, Mario Russo, Rosario Giustolisi
Journal: Blood
Blood (1999) 94 (4): 1479–1480.
https://doi.org/10.1182/blood.V94.4.1479
Published: 1999